Histological features in western patients with idiopathic non-cirrhotic portal hypertension

Histopathology

Volumn 62, Issue 7, 2013, Pages 1083-1091

  Verheij, Joanne ^a   Schouten, Jeoffrey N L ^b   Komuta, Mina ^c   Nevens, Frederik ^c   Hansen, Bettina E ^b   Janssen, Harry L A ^b   Roskams, Tania ^c  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Idiopathic non cirrhotic portal hypertension; Nodular regeneration; Paraportal shunting vessels; Perisinusoidal fibrosis; Phlebosclerosis; Portal tract remnants; Sinusoidal dilatation

Indexed keywords

ADULT; AGED; ARTICLE; CHILD; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IDIOPATHIC DISEASE; IDIOPATHIC NON CIRRHOTIC PORTAL HYPERTENSION; LIVER BIOPSY; LIVER FIBROSIS; LIVER REGENERATION; MAJOR CLINICAL STUDY; MALE; PORTAL HYPERTENSION; PORTAL VEIN THROMBOSIS; PRIORITY JOURNAL; SCHOOL CHILD; VEIN DILATATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOPSY; CHILD; DILATATION, PATHOLOGIC; FEMALE; HIV INFECTIONS; HUMANS; HYPERTENSION, PORTAL; LIVER CIRRHOSIS; MALE; MIDDLE AGED; PORTAL VEIN; REGENERATION; SCLEROSIS; VENOUS THROMBOSIS; YOUNG ADULT;

EID: 84877926016     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/his.12114     Document Type: Article

References (34)

1. Schouten JN, Garcia-Pagan JC, Valla DC, Janssen HL. Idiopathic noncirrhotic portal hypertension. Hepatology 2011; 54; 1071-1081.
2. Nakanuma Y, Hoso M, Sasaki M etal. Histopathology of the liver in non-cirrhotic portal hypertension of unknown aetiology. Histopathology 1996; 28; 195-204.
3. Ohbu M, Okudaira M, Watanabe K, Kaneko S, Takai T. Histopathological study of intrahepatic aberrant vessels in cases of noncirrhotic portal hypertension. Hepatology 1994; 20; 302-308.
4. Sarin SK, Kapoor D. Non-cirrhotic portal fibrosis: current concepts and management. J. Gastroenterol. Hepatol. 2002; 17; 526-534.
5. Schouten JN, Nevens F, Hansen B etal. Idiopathic noncirrhotic portal hypertension is associated with poor survival: results of a long-term cohort study. Aliment. Pharmacol. Ther. 2012; 35; 1424-1433.
6. International Working Party. Terminology of nodular hepatocellular lesions. Hepatology 1995; 22; 983-993.
7. Wanless IR. Micronodular transformation (nodular regenerative hyperplasia) of the liver: a report of 64 cases among 2, 500 autopsies and a new classification of benign hepatocellular nodules. Hepatology 1990; 11; 787-797.
8. Bioulac-Sage P, Le Bail B, Bernard PH, Balabaud C. Hepatoportal sclerosis. Semin. Liver Dis. 1995; 15; 329-339.
9. Ludwig J, Hashimoto E, Obata H, Baldus WP. Idiopathic portal hypertension; a histopathological study of 26 Japanese cases. Histopathology 1993; 22; 227-234.
10. Ludwig J, Hashimoto E, Obata H, Baldus WP. Idiopathic portal hypertension. Hepatology 1993; 17; 1157-1162.
11. Sherlock S, Feldman CA, Moran B, Scheuer PJ. Partial nodular transformation of the liver with portal hypertension. Am. J. Med. 1966; 40; 195-203.
12. Cazals-Hatem D, Hillaire S, Rudler M etal. Obliterative portal venopathy: portal hypertension is not always present at diagnosis. J. Hepatol. 2011; 54; 455-461.
13. Krasinskas AM, Eghtesad B, Kamath PS, Demetris AJ, Abraham SC. Liver transplantation for severe intrahepatic noncirrhotic portal hypertension. Liver Transpl. 2005; 11; 627-634; discussion 610-621.
14. Roskams T, Baptista A, Bianchi L etal. Histopathology of portal hypertension: a practical guideline. Histopathology 2003; 42; 2-13.
15. Hillaire S, Bonte E, Denninger MH etal. Idiopathic non-cirrhotic intrahepatic portal hypertension in the West: a re-evaluation in 28 patients. Gut 2002; 51; 275-280.
16. Nevens F, Staessen D, Sciot R etal. Clinical aspects of incomplete septal cirrhosis in comparison with macronodular cirrhosis. Gastroenterology 1994; 106; 459-463.
17. Nevens F, Fevery J, Van Steenbergen W, Sciot R, Desmet V, De Groote J. Arsenic and non-cirrhotic portal hypertension. A report of eight cases. J. Hepatol. 1990; 11; 80-85.
18. Sciot R, Staessen D, Van Damme B etal. Incomplete septal cirrhosis: histopathological aspects. Histopathology 1988; 13; 593-603.
19. Popper H. Pathogenesis and classification of liver cirrhosis. Med. Klin. 1969; 64; 89-92.
20. Sarin SK, Kumar A, Chawla YK etal. Noncirrhotic portal fibrosis/idiopathic portal hypertension: APASL recommendations for diagnosis and treatment. Hepatol. Int. 2007; 1; 398-413.
21. Okudaira M, Ohbu M, Okuda K. Idiopathic portal hypertension and its pathology. Semin. Liver Dis. 2002; 22; 59-72.
22. Wanless IR. Noncirrhotic portal hypertension: recent concepts. Prog. Liver Dis. 1996; 14; 265-278.
23. Wanless IR, Nakashima E, Sherman M. Regression of human cirrhosis. Morphologic features and the genesis of incomplete septal cirrhosis. Arch. Pathol. Lab. Med. 2000; 124; 1599-1607.
24. Krasinskas AM, Goldsmith JD, Burke A, Furth EE. Abnormal intrahepatic portal vasculature in native and allograft liver biopsies: a comparative analysis. Am. J. Surg. Pathol. 2005; 29; 1382-1388.
25. Wanless IR, Huang W-Y. Vascular disorders. MacSween's pathology of the liver. 6th edn. Philadelphia: Churchill Livingstone Elsevier, 2012.
26. McEntee MF, Wright KN, Wanless I, DeVovo R, Schneider JF, Shull R. Noncirrhotic portal hypertension and nodular regenerative hyperplasia of the liver in dogs with mucopolysaccharidosis type I. Hepatology 1998; 28; 385-390.
27. Ward NL, Haninec AL, Van Slyke P etal. Angiopoietin-1 causes reversible degradation of the portal microcirculation in mice: implications for treatment of liver disease. Am. J. Pathol. 2004; 165; 889-899.
28. Wanless IR, Peterson P, Das A, Boitnott JK, Moore GW, Bernier V. Hepatic vascular disease and portal hypertension in polycythemia vera and agnogenic myeloid metaplasia: a clinicopathological study of 145 patients examined at autopsy. Hepatology 1990; 12; 1166-1174.
29. Chang PE, Miquel R, Blanco JL etal. Idiopathic portal hypertension in patients with HIV infection treated with highly active antiretroviral therapy. Am. J. Gastroenterol. 2009; 104; 1707-1714.
30. Cotte L, Benet T, Billioud C etal. The role of nucleoside and nucleotide analogues in nodular regenerative hyperplasia in HIV-infected patients: a case control study. J. Hepatol. 2011; 54; 489-496.
31. Mallet V, Blanchard P, Verkarre V etal. Nodular regenerative hyperplasia is a new cause of chronic liver disease in HIV-infected patients. AIDS 2007; 21; 187-192.
32. Brivet FG, Nion I, Megarbane B etal. Fatal lactic acidosis and liver steatosis associated with didanosine and stavudine treatment: a respiratory chain dysfunction? J. Hepatol. 2000; 32; 364-365.
33. Bissell DM, Gores GJ, Laskin DL, Hoofnagle JH. Drug-induced liver injury: mechanisms and test systems. Hepatology 2001; 33; 1009-1013.
34. Dhiman RK, Chawla Y, Vasishta RK etal. Non-cirrhotic portal fibrosis (idiopathic portal hypertension): experience with 151 patients and a review of the literature. J. Gastroenterol. Hepatol. 2002; 17; 6-16.